To be able to use the full range of Shopware 6, we recommend activating Javascript in your browser.

Welcome to JPT

Your Cart
US$0.00

Press releases & news

Please have a look at our recent news or browse the archive.

Press releases & news

NEW PepMix Peptide Pools for the highly mutated SARS2 variant Pirola (BA.2.86)!

Let us introduce ourselves – Customer Support Team

Unlock the Secrets of Peptides: Get Your Free eBook 'The Peptide ABC' Today!

Take Control of Your T Cell Assays - Recent Publications Covering our Peptide Control Pools

Host a free ELISpot Workshop in your city or join us in Antwerp!

We will be at this years’ SITC conference!

NEW PepMix Peptide Pools for current SARS2 variants

Let me introduce myself! - Aude-Marie Alem

Take Control of Your T Cell Assays!

Elevate Your Proteomics Assays: Peptide Quantification for Precision Proteomics

NEW: Monkeypox & Vaccinia Peptide Pools & Microarrays!

NEW: PepMix Collections for SARS-CoV-2 Wuhan & Variants

Our Peptides in Action: Recent Publications in Oncology!

We will be at the annual FOCIS in San Francisco!

Recent Publications on Infectious Diseases

Check Out Our New Fully Purified Omicron Pools!

Our new US-based peptide contact – Aude-Marie Alem

The Largest Variety of Custom Peptide Formats

Join us at CIMT in Mainz & ISCT in San Francisco 2022!

Study Cross-reactivity & COVID-19 Vaccine Responses!

JPT Maintains Quality Leadership - ISO 9001:2015 Recertification

Let our Antibody Profiling Assays Work for You!

NEW: PepMixes for Omicron BA.2 Spike & RBD

Improve Your Phosphoproteomic Assays

Identify Epitope-resolved Antibody Responses with Peptide Microarrays

Introducing JPT PepMix™ Pan Select Peptide Pools – the smartest approach to broad antigen-specific T-cell stimulation with single peptide pools

NEW: PepMix™ & PepStar™ for Adenovirus Proteins available

NEW: Omicron & Lambda PepMix™ & PepStar™

Happy New Year! Our Highlights 2021 are...

New AppNote Available: SARS-CoV-2 cross-reactivity upon infection & vaccination

JPT’s peptides continue to contribute to important SARS-CoV-2 publications

JPT Launches a New Website!

NEW: Delta & Kappa SARS-CoV-2 PepMixes™

NEW: SARS-CoV-2 PepMixes™ for Brazil, South Africa & California Mutations

NEW: Virus-spanning PepMix™ Select Epitope Pools from JPT

Identify Epitope Resolved Antibody Responses with SARS-CoV-2 Peptide Microarrays

NEW Antigen Peptide Pools: SARS-CoV-2 B.1.1.7 (UK) & HCoV NCAP PepMixes™

Have a Healthy New Year! 5 Things we are grateful for

13 NEW Standardization Kits for MS based Neo-epitope Identification

Study SARS CoV-2 Cross-Reactivity with MERS, SARS & Seasonal Coronaviruses

What’s new in Neo-Epitope Discovery & Therapy?

Infectious diseases beyond COVID-19 – JPT’s peptide formats in the literature

Everything You Need to Know about Peptides

JPT’s SARS CoV-2 Products Deliver Meaningful Results!

SARS-COV-2 Spike & NCAP Mutations as PepMix™ Peptide Pools

Study SARS CoV-2 Cross Reactive T-Cells with EMPS-Peptides from Endemic HCoV’s

SARS COV-2 Mass Spec Reference Kit Released!

JPT’s Innovation Featured on Cover of Proteomics Journal

Mission Completed! Purified SARS-CoV-2 PepMixes™ & Peptide Arrays

NEW: Additional SARS-CoV-2 PepMixes™ & Antigen Peptides

New! SARS-CoV-2 Spike & NCAP Epitope Mapping Peptide Sets

COVID-19: JPT receives status as Systemically Important Company

NEW! SARS-CoV-2 PepMix™ Peptide Pools & Microarrays

Measure T-Cell Clone Specificity with PepMaster™

Peptide Pool Concepts from Discovery to the Clinic

JPT Supports Immudex’ Annual Elispot Proficiency Panel 2020

Our Highlights in 2019

30 Years After The Wall: Eastern German Success Stories

JPT turns 15!

Boost Peptide Reliability with Peptide Analysis Services

Have a look at Proteomics Publications using SpikeTides™ & Co.

Are you going to FOCiS or BIO?

Meet us at AAI, CIMT, Brisbane Immunotherapy & ISCT!

NEW Cell Activation Kit: PepSup™

JPT Maintains Quality Leadership - ISO 9001:2015 Recertification

Free ELISPOT Workshops in Belgium & The Netherlands

Superior Positive Control Pools for Better T-Cell Assays

JPT launches The Human Proteome Peptide Catalog

A New Peptide Approach to meet Antigen Sequence Diversity

PROCAL - a new RT Standardization Kit for LC-MS based Proteomics

TheraCode GmbH acquires JPT Peptide Technologies